Abstract:Methods: NIP patients (n = 106) admitted between January 2020 and March 2021 were selected and grouped as follows according to the random number table method: a dissection group treated with dynamical-system surgery under nasal endoscope and an ablation group treated with LTPRA. The clinical curative effects of the two procedures were compared, and the related indexes (operation time (OT), intraoperative blood loss (IBL), and length of stay (LOS)) and postoperative adverse reactions (ARs) were counted. In addition, fasting venous blood samples were collected before treatment (T0), as well as 3 (T1) and 7 days after treatment (T2) to detect inflammatory factors (IFs; C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)) and T lymphocyte subsets (CD3+, CD4+, and CD8+). Finally, all patients received a one-year follow-up to compare the differences in prognostic survival rate and disease recurrence rate between groups. Results: The ablation group has a similar LOS to the dissection group (P > 0.05), but lower OT and IBL. No marked difference was observed between groups in terms of the total effective rate (P > 0.05), but the adverse reaction rate was higher in the dissection group compared with the ablation group (P < 0.05). Compared with T0, elevated CRP, IL-6, TNF-α, and CD3+ were observed in both cohorts at T1, with lower levels in the ablation group as compared to the dissection group, while CD4+ and CD8+ decreased in both cohorts and were higher in the ablation group (P < 0.05). Meanwhile, the levels of CRP, IL-6, TNF-α, and CD3+ in both groups were lower at T2 compared to T1, whereas those of CD4+ and CD8+ in both groups were higher at T2 compared to T1 (P < 0.05). As indicated by the statistics on prognostic follow-up, the two cohorts of patients showed no evident difference in the 1-year survival rate and disease recurrence rate (P > 0.05). Conclusions: Both dynamical-system surgery under nasal endoscope and LTPRA have good therapeutic effects on NIP, but the latter is safer and can effectively reduce the postoperative inflammatory reaction of patients and maintain the stability of immune function, which has higher clinical application value.

Different Surgical Approaches and Effects in Nasal Inverted Papillom

[Management of Sinonasal Inverted Papilloma: Endoscopic Approach and Lateral Rhinotomy].

[Management of Sinonasal Inverted Papilloma: Endoscopic Excision Vs Traditional Procedures].

Nasal Endoscopy United with External Approach Surgery for Sinonasal Inverted Papilloma

[The Value of Nasal Endoscopy in the Surgery of the Nasal Inverted Papillomas].

Characteristics of Nasal Inverted Papilloma and Its Malignant Transformation: A Study of Cell Proliferation and Programmed Cell Death

Surgery for Treatment of Inverting Papilloma in Nasal Cavity and Sinus under the Nose Endoscope

Clinical Analysis of Nasal and Laryngeal Neuroendocrine Carcinoma

Endoscopic smgery in the treatment of nasal cavity and maxillary sinus inverted papilloma

Dynamic Incision under Nasal Endoscope and Low-Temperature Plasma Radiofrequency Ablation for Nasal Inverted Papilloma: An Analysis of Differences in Efficacy and the Destructive Effect on Immune Function

[Clinical Analysis of the Primary Nasal Septum Mass in 253 Cases].

Endoscopic surgical approach of sinonasal inverted papilloma: A case report and mini review

Endoscopic Management of the Inverted Papilloma in Frontal Sinus

Relationship Between Prognosis of Nasal Inverted Papilloma and Human Papillomavirus Types

Nasal Cavity Treatment and Local Medication after Endoscopic Sinus Surgery of Rhino-Sinus Benign Lesions

Management of Maxillary Sinus Inverted Papilloma Via Endoscopic Partial Medial Maxillectomy with an Inferior Turbinate Reversing Approach

Survival outcomes after endoscopic resection for sinonasal squamous cell carcinoma arising on inverted papilloma

Quality-of-Life Outcomes Following Endoscopic Resection of Sinonasal Inverted Papilloma

Comparison of Current Staging Systems for Sinonasal Inverted Papilloma

Comparison of Two Approaches to the Surgical Management of Juvenile Nasopharyngeal Angiofibroma Stages I and Ii

Management of Maxillary Sinus Inverted Papilloma Via Transnasal Endoscopic Anterior and Medial Maxillectomy